1. Home
  2. GCTK vs NXTT Comparison

GCTK vs NXTT Comparison

Compare GCTK & NXTT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GCTK
  • NXTT
  • Stock Information
  • Founded
  • GCTK 2001
  • NXTT 2019
  • Country
  • GCTK United States
  • NXTT China
  • Employees
  • GCTK N/A
  • NXTT N/A
  • Industry
  • GCTK Medical/Dental Instruments
  • NXTT
  • Sector
  • GCTK Health Care
  • NXTT
  • Exchange
  • GCTK Nasdaq
  • NXTT NYSE
  • Market Cap
  • GCTK 7.6M
  • NXTT 8.4M
  • IPO Year
  • GCTK N/A
  • NXTT N/A
  • Fundamental
  • Price
  • GCTK $0.26
  • NXTT $1.91
  • Analyst Decision
  • GCTK
  • NXTT
  • Analyst Count
  • GCTK 0
  • NXTT 0
  • Target Price
  • GCTK N/A
  • NXTT N/A
  • AVG Volume (30 Days)
  • GCTK 696.8K
  • NXTT 574.1K
  • Earning Date
  • GCTK 11-26-2024
  • NXTT 11-26-2024
  • Dividend Yield
  • GCTK N/A
  • NXTT N/A
  • EPS Growth
  • GCTK N/A
  • NXTT N/A
  • EPS
  • GCTK N/A
  • NXTT 3.73
  • Revenue
  • GCTK N/A
  • NXTT $999,472.00
  • Revenue This Year
  • GCTK N/A
  • NXTT N/A
  • Revenue Next Year
  • GCTK N/A
  • NXTT N/A
  • P/E Ratio
  • GCTK N/A
  • NXTT $0.52
  • Revenue Growth
  • GCTK N/A
  • NXTT N/A
  • 52 Week Low
  • GCTK $0.25
  • NXTT $0.94
  • 52 Week High
  • GCTK $4.95
  • NXTT $7.74
  • Technical
  • Relative Strength Index (RSI)
  • GCTK 21.06
  • NXTT 72.19
  • Support Level
  • GCTK $1.20
  • NXTT $0.97
  • Resistance Level
  • GCTK $1.79
  • NXTT $3.14
  • Average True Range (ATR)
  • GCTK 0.30
  • NXTT 0.35
  • MACD
  • GCTK -0.12
  • NXTT 0.11
  • Stochastic Oscillator
  • GCTK 0.85
  • NXTT 43.18

About GCTK GlucoTrack Inc.

GlucoTrack Inc is a medical device company. It focuses on the design, development, and commercialization of non-invasive glucose monitoring devices for use by people with diabetes and pre-diabetics. The company has developed a non-invasive glucose monitor, the GlucoTrack model DF-F glucose monitoring device, which is designed to help people with diabetes and pre-diabetics obtain glucose level readings without the pain, inconvenience, and difficulty of conventional spot finger stick devices. It has completed a feasibility study successfully demonstrating that a minimum two-year implant life is highly probable with the sensor design. They have also initiated an animal study with an initial prototype system that has thus far demonstrated a simple implant procedure and good functionality.

About NXTT NEXT TECHNOLOGY HOLDING INC

Next Technology Holding Inc pursues two corporate strategies. One business strategy is to continue providing software development services, and the other strategy is to acquire and hold Bitcoin. It provides AI-enabled software development services to its customers, which include developing, designing, and implementing various SAAS software solutions for businesses of all types, including industrial and other businesses. Its bitcoin acquisition strategy generally involves acquiring bitcoin with its liquid assets that exceed working capital requirements, and from time to time, subject to market conditions, issuing debt or equity securities or engaging in other capital raising transactions to use the proceeds to purchase bitcoin.

Share on Social Networks: